ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Mizuho Analysts Give Biogen (BIIB) a $400.00 Price Target
December 26, 2017Mizuho set a $400.00 price target on Biogen (NASDAQ:BIIB) in a research report released on Thursday. The brokerage currently has a buy rating on the biotechnology company’s stock. -
Biogen and Alkermes announce collaboration for MS treatment ALKS 8700
December 07, 2017Biogen to bring its MS expertise to the commercialisation of ALKS 8700, a therapy intended to bring a differentiated gastrointestinal tolerability profile.
Pharma Sources Insight January 2025
